MHRAgovuk· @MHRAgovuk · X·· 3 小时前精选AI 评分42
AI 导读
MHRA表示，MHRA与NICE的同步审评路径正在加快，首个药品预计今年内完成整个流程。该路径旨在实现上市许可与价值评估的同步决策，并整合科学建议，MHRA发布了关于其实际运行情况的更新。
推荐理由
MHRA与NICE同步审评路径的进展更新，可了解英国在上市许可与价值评估衔接上的机制实践。
正文
The MHRA-NICE aligned pathway is gathering pace, with the first medicine expected to complete its journey later this year.
Read our update on how same time decisions on licencing and value, and integrated scientific advice, are working in practice: https://brnw.ch/21x64rY
来源：MHRAgovuk · x.com